Growth hormone axis treatments for HIV-associated lipodystrophy: a systematic review of placebo-controlled trials
Each batch is analysed by an independent third-party laboratory using HPLC to confirm purity and mass spectrometry to confirm identity
Braunstein CR, Noronha JC, Khan TA, Mejia SB, Wolever TMS, Josse RG, et al
J.SanetoR
Glucagon-like Peptide Receptor Agonists (GLP1-RA) A systematic review and the above-mentioned retrospective study have suggested effectiveness of GLP1-RA to reduce glycemic variability and hypoglycemia in PBH and demonstrated patient therapeutic preference
Four major 56-week phase III randomized, double-blind, placebo-controlled trials have shown the therapeutic effect of SR (COR-I, COR-II, COR-BMOD, COR-DIABETES) in different dosage combinations (see Table 6)